These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 16513011)

  • 21. [Effects of levonorgestrel-releasing intrauterine system on endometrial estrogen and progesterone receptors in patients with endometrial hyperplasia].
    Weng M; Li L; Feng S; Xie M; Hong S
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Sep; 32(9):1350-4. PubMed ID: 22985581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modern management of abnormal uterine bleeding: the levonorgestrel intra-uterine system.
    Mansour D
    Best Pract Res Clin Obstet Gynaecol; 2007 Dec; 21(6):1007-21. PubMed ID: 17544330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.
    Bian J; Shao H; Liu H; Li H; Fang L; Xing C; Wang L; Tao M
    Reprod Sci; 2015 Jun; 22(6):758-66. PubMed ID: 25536958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after 3 years of estrogen substitution therapy.
    Wildemeersch D; Schacht E; Wildemeersch P; Calleweart K; Pylyser K; De Wever N
    Maturitas; 2004 May; 48(1):65-70. PubMed ID: 15223110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis.
    Gallos ID; Shehmar M; Thangaratinam S; Papapostolou TK; Coomarasamy A; Gupta JK
    Am J Obstet Gynecol; 2010 Dec; 203(6):547.e1-10. PubMed ID: 20934679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.
    Varma R; Soneja H; Bhatia K; Ganesan R; Rollason T; Clark TJ; Gupta JK
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):169-75. PubMed ID: 18440693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Levonorgestrel-releasing intrauterine system Mirena® (Bayer) for the prevention and treatment of endometrial adenocarcinoma and the incidence of other malignancies in women].
    Jóźwik M; Jóźwik M; Modzelewska B; Niewińska M; Jóźwik M
    Ginekol Pol; 2015 Apr; 86(4):305-10. PubMed ID: 26117991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of endometrial hyperplasia without atypia in peri- and postmenopausal women with a levonorgestrel intrauterine device.
    Haimovich S; Checa MA; Mancebo G; Fusté P; Carreras R
    Menopause; 2008; 15(5):1002-4. PubMed ID: 18451744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of a levonorgestrel-releasing intrauterine system for treating endometrial hyperplasia in patients with polycystic ovary syndrome.
    Lin M; Xu X; Wang Y; Hu Y; Zhao Y
    Gynecol Obstet Invest; 2014; 78(1):41-4. PubMed ID: 24852134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined hormone therapy in hyperplasia of the endometrium].
    Bespoiasnaia VV; Tumasian KP; Voronovskaia IV
    Lik Sprava; 2000 Sep; (6):49-52. PubMed ID: 11452920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endometrial polyp and the levonorgestrel intrauterine system--a case report and literature review.
    Sinha A; Nwosu EC
    J Obstet Gynaecol; 2002 Nov; 22(6):695. PubMed ID: 12554277
    [No Abstract]   [Full Text] [Related]  

  • 33. The levonorgestrel intrauterine system for use in peri- and postmenopausal women.
    Sitruk-Ware R
    Contraception; 2007 Jun; 75(6 Suppl):S155-60. PubMed ID: 17531609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The levonorgestrel-releasing intrauterine system in modern gynaecology.
    McGavigan CJ; Owen P
    Br J Hosp Med (Lond); 2005 Oct; 66(10):574-7. PubMed ID: 16255257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial morphology and bleeding patterns as a function of progestogen supplementation.
    Sturdee DW
    Int J Fertil Menopausal Stud; 1996; 41(1):22-8. PubMed ID: 8673153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulated progesterone receptor A and B coinciding with successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system.
    Orbo A; Arnes M; Pettersen I; Larsen K; Hanssen K; Moe B
    Acta Obstet Gynecol Scand; 2010 Nov; 89(11):1438-46. PubMed ID: 20955098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous intrauterine compared with cyclic oral progestin administration in perimenopausal HRT.
    Boon J; Scholten PC; Oldenhave A; Heintz AP
    Maturitas; 2003 Sep; 46(1):69-77. PubMed ID: 12963171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term use of the levonorgestrel-releasing intrauterine system.
    Inki P
    Contraception; 2007 Jun; 75(6 Suppl):S161-6. PubMed ID: 17531611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study.
    Scarselli G; Bargelli G; Taddei GL; Marchionni M; Peruzzi E; Pieralli A; Mattei A; Buccoliero AM; Fambrini M
    Fertil Steril; 2011 Jan; 95(1):420-2. PubMed ID: 20723889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levonorgestrel-Releasing Intrauterine System vs. Oral Progestins for Treatment of Endometrial Hyperplasia.
    Liegl S
    Am Fam Physician; 2016 Jun; 93(11):948-9. PubMed ID: 27281840
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.